L865-2030 Screening compound: 1-(6-{[(butan-2-yl)carbamoyl]methyl}-7-oxo-6H,7H-[1,3]thiazolo[4,5-d]pyrimidin-2-yl)-N-(propan-2-yl)piperidine-4-carboxamide

L865-2030 Screening compound: 1-(6-{[(butan-2-yl)carbamoyl]methyl}-7-oxo-6H,7H-[1,3]thiazolo[4,5-d]pyrimidin-2-yl)-N-(propan-2-yl)piperidine-4-carboxamide
L865-2030 Screening compound: 1-(6-{[(butan-2-yl)carbamoyl]methyl}-7-oxo-6H,7H-[1,3]thiazolo[4,5-d]pyrimidin-2-yl)-N-(propan-2-yl)piperidine-4-carboxamide alternative view

Chemical Structure Depiction of ChemDiv screening compound L865-2030
1-(6-{[(butan-2-yl)carbamoyl]methyl}-7-oxo-6H,7H-[1,3]thiazolo[4,5-d]pyrimidin-2-yl)-N-(propan-2-yl)piperidine-4-carboxamide

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

L865-2030

Molecular Formula

C20H30N6O3S (C20 H30 N6 O3 S)

Compound Name

1-(6-{[(butan-2-yl)carbamoyl]methyl}-7-oxo-6H,7H-[1,3]thiazolo[4,5-d]pyrimidin-2-yl)-N-(propan-2-yl)piperidine-4-carboxamide

IUPAC name

1-(6-{[(butan-2-yl)carbamoyl]methyl}-7-oxo-6H7H-[13]thiazolo[45-d]pyrimidin-2-yl)-N-(propan-2-yl)piperidine-4-carboxamide

SMILES

CCC(C)NC(CN(C=Nc1c2sc(N(CC3)CCC3C(NC(C)C)=O)n1)C2=O)=O

InChI

InChI=1S/C20H30N6O3S/c1-5-13(4)23-15(27)10-26-11-21-17-16(19(26)29)30-20(24-17)25-8-6-14(7-9-25)18(28)22-12(2)3/h11-14H,5-10H2,1-4H3,(H,22,28)(H,23,27)/t13-/m0/s1

InChI Key

CFLFDKZMNPSWII-ZDUSSCGKSA-N

MDL Number (MFCD)

MFCD27482695

Chemical and Physical Properties

Saltdata

n/a

Molecular Weight

434.56

Hydrogen Bond Acceptors Count

8.00

Hydrogen Bond Donors Count

2.00

Rotatable Bond Count

9.00

Number of Nitrogen and Oxygen Atoms

9

Partition Coefficient, logP

1.447

Distribution Coefficient, logD

1.447

Water Solubility, LogSw

-2.04

Polar Surface Area

88.031

Acid Dissociation Constant (pKa)

14.90

Base Dissociation Constant (pKb)

5.88

Number of Chiral Centers

1.00

Percent sp3 carbon bonding

65.00

L865-2030 in Drug Discovery

Included in Screening Libraries

Macl-GPIb alpha Interaction Library (22969 compounds)

Nonpeptide Peptidomimetics PPI Library (18997 compounds)

Protein-Protein Interaction Library (218420 compounds)

Targeted Diversity Library (40567 compounds)

Included in 1.7M Stock Database

Therapeutical areas:
  • Hemic and lymphatic
  • Cardiovascular
Mechanism of action:
  • PPI modulators
  • PPI modulators
Structure:
  • Mimetics

References: we are preparing a list of scientific research reports with L865-2030 chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound L865-2030?
Check Price and Availability of L865-2030, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of L865-2030 you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for L865-2030
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for L865-2030
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of L865-2030 available by request